ANNE MARCEAU: Open Payments
NPI 1265482012 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 33 payments from 16 companies in 2025. Trend: 2023 $379 · 2024 $455 · 2025 $864
Food & beverage: $587Education: $277
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $132 |
| AstraZeneca Pharmaceuticals LP | 4 | $125 |
| SEAGEN INC. | 1 | $99 |
| PFIZER INC. | 6 | $68 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| ARRAY BIOPHARMA INC | 3 | $61 |
| Genmab U.S., Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $44 |
| BeOne Medicines USA, Inc. | 1 | $35 |
Products named: Enhertu, XTANDI, KEYTRUDA, Tivdak, JEMPERLI, BRAFTOVI, IMFINZI, BRUKINSA.
Industry payments across UT — which companies pay providers there.
